BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38519366)

  • 1. Emerging roles of TBK1 in cancer immunobiology.
    Miranda A; Shirley CA; Jenkins RW
    Trends Cancer; 2024 Jun; 10(6):531-540. PubMed ID: 38519366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TANK-binding kinase 1 (TBK1) in cancer.
    Revach OY; Liu S; Jenkins RW
    Expert Opin Ther Targets; 2020 Nov; 24(11):1065-1078. PubMed ID: 32962465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on the role of TANK-binding kinase 1 signaling in cancer.
    Alam M; Hasan GM; Hassan MI
    Int J Biol Macromol; 2021 Jul; 183():2364-2375. PubMed ID: 34111484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of TBK1 in cancer pathogenesis and anticancer immunity.
    Runde AP; Mack R; S J PB; Zhang J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling.
    Brown MC; Mosaheb MM; Mohme M; McKay ZP; Holl EK; Kastan JP; Yang Y; Beasley GM; Hwang ES; Ashley DM; Bigner DD; Nair SK; Gromeier M
    Nat Commun; 2021 Mar; 12(1):1858. PubMed ID: 33767151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.
    He TS; Huang J; Chen T; Zhang Z; Cai K; Yu J; Xu LG
    Microbiol Spectr; 2021 Dec; 9(3):e0145821. PubMed ID: 34908452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease.
    Herhaus L
    Matrix Biol; 2021 Jun; 100-101():84-98. PubMed ID: 33454423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of TBK1-mediated antiviral immunity.
    Zhao W
    FEBS Lett; 2013 Mar; 587(6):542-8. PubMed ID: 23395611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TBK1 mediates crosstalk between the innate immune response and autophagy.
    Weidberg H; Elazar Z
    Sci Signal; 2011 Aug; 4(187):pe39. PubMed ID: 21868362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.
    Ning YJ; Feng K; Min YQ; Deng F; Hu Z; Wang H
    J Biol Chem; 2017 Oct; 292(40):16722-16733. PubMed ID: 28848048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eph Receptors in the Immunosuppressive Tumor Microenvironment.
    Janes PW; Vail ME; Ernst M; Scott AM
    Cancer Res; 2021 Feb; 81(4):801-805. PubMed ID: 33177063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1.
    Helgason E; Phung QT; Dueber EC
    FEBS Lett; 2013 Apr; 587(8):1230-7. PubMed ID: 23395801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity.
    Meng F; Yu Z; Zhang D; Chen S; Guan H; Zhou R; Wu Q; Zhang Q; Liu S; Venkat Ramani MK; Yang B; Ba XQ; Zhang J; Huang J; Bai X; Qin J; Feng XH; Ouyang S; Zhang YJ; Liang T; Xu P
    Mol Cell; 2021 Oct; 81(20):4147-4164.e7. PubMed ID: 34453890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway.
    Weil R; Laplantine E; Génin P
    Cytokine Growth Factor Rev; 2016 Jun; 29():23-33. PubMed ID: 26976762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.
    Schlütermann D; Berleth N; Deitersen J; Wallot-Hieke N; Friesen O; Wu W; Stuhldreier F; Sun Y; Berning L; Friedrich A; Mendiburo MJ; Peter C; Wiek C; Hanenberg H; Stefanski A; Stühler K; Stork B
    Sci Rep; 2021 Jul; 11(1):13863. PubMed ID: 34226595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxiredoxin 1 Interacts with TBK1/IKKε and Negatively Regulates Pseudorabies Virus Propagation by Promoting Innate Immunity.
    Lv L; Bai J; Gao Y; Jin L; Wang X; Cao M; Liu X; Jiang P
    J Virol; 2021 Sep; 95(19):e0092321. PubMed ID: 34260286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF1A regulates the crosstalk between innate immune responses and MAFLD by mediating autophagic degradation of TBK1.
    Qin Y; Qiu D; Zhang Q
    Autophagy; 2023 Mar; 19(3):1026-1027. PubMed ID: 35944095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer.
    Ritter JL; Zhu Z; Thai TC; Mahadevan NR; Mertins P; Knelson EH; Piel BP; Han S; Jaffe JD; Carr SA; Barbie DA; Barbie TU
    Cancer Res; 2020 Jan; 80(1):44-56. PubMed ID: 31662325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.